By tracking and understanding which host cell pathways are manipulated by these T.
gondii proteins, scientists can identify potential new targets to develop more effective therapies against highly aggressive solid tumors.
Not exact matches
In the new study, scientists built upon previous discoveries that a safe, non-reproducing vaccine strain of T.
gondii could cure mice of several types of solid tumors, and identified which parasite
proteins and which immunological pathways are required to break immune tolerance.
Scientists identified the specific
proteins secreted by the parasite Toxoplasma
gondii that cause the immune system in mice to attack established ovarian tumors.
Their results demonstrate that specific rhoptry and dense granule effector
proteins that T.
gondii secretes before and after host cell invasion, respectively, control the development of an effective host antitumor response, and increase the survival of mice with ovarian tumors.
Using a combination of human or specially engineered mouse cells in vitro and in vivo animal models, study senior investigator Judy Lieberman, MD, PhD; study lead investigator Farokh Dotiwala, PhD, with a team lead by the Brazilian parasitologist Ricardo Gazzinelli, DSc, DVM, found that when an immune killer cell, such as a T - cell or natural killer (NK) cell, encounters a cell infected with any of three intracellular parasites (Trypanosoma cruzi, Toxoplasma
gondii or Leishmania major), it releases three
proteins that together kill both the parasite and the infected cell:
Toxoplasma
gondii dense granule
protein 3 (GRA3) is a type I transmembrane
protein that possesses a cytoplasmic dilysine (KKXX) endoplasmic reticulum (ER) retrieval motif.
Moreover, recent studies show that T.
gondii can deliver effector
proteins into cells that it does not invade [33], [34], and that these
proteins can manipulate host cells without active parasite replication [35].
We further aim to understand origins and causes for evolutionary diversity in chromosome segregation
protein networks, using various model organisms including Tetrahymena thermophila and Toxoplasma
gondii.
Specifically, we have expressed
proteins and obtained structures from 5 Plasmodium species, Cryptosporidium parvum and Toxoplasma
gondii, as well as Trypanosomaand Leishmania.